Insmed Accretion Of Debt Discount, Marketable Securities decreased by 37.4% to $6.51M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 21.8%, from $8.33M to $6.51M.
Reflects the effective interest rate of financial instruments; changes indicate shifts in the company's debt or investment portfolio structure.
The process of increasing the carrying value of debt or securities that were issued at a discount to their face value. T...
Standard for companies holding significant debt or investment securities.
other_accretion_of_debt_discount_marketable_securities| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.96M | $0.00 | $6.17M | $11.03M | $8.33M | $7.58M | $12.04M | $10.40M | $6.51M |
| QoQ Change | — | — | — | — | — | — | — | -100.0% | — | +78.7% | -24.4% | -9.0% | +58.9% | -13.7% | -37.4% |
| YoY Change | — | — | — | — | — | — | — | — | — | — | +324.5% | — | +95.2% | -5.7% | -21.8% |